Target
Ephrin type-A receptor 3
Ligand
BDBM50302163
Substrate
n/a
Meas. Tech.
ChEMBL_599561 (CHEMBL1038371)
IC50
7000±n/a nM
Citation
 Wu, JPFleck, RBrickwood, JCapolino, ACatron, KChen, ZCywin, CEmeigh, JFoerst, MGinn, JHrapchak, MHickey, EHao, MHKashem, MLi, JLiu, WMorwick, TNelson, RMarshall, DMartin, LNemoto, PPotocki, ILiuzzi, MPeet, GWScouten, EStefany, DTurner, MWeldon, SZimmitti, CSpero, DKelly, TA The discovery of thienopyridine analogues as potent IkappaB kinase beta inhibitors. Part II. Bioorg Med Chem Lett 19:5547-51 (2009) [PubMed]  Article 
Target
Name:
Ephrin type-A receptor 3
Synonyms:
EPHA3 | EPHA3_HUMAN | ETK | ETK1 | Ephrin receptor | Ephrin type-A receptor 3 | Ephrin type-A receptor 3 (EPHA3) | HEK | TYRO4
Type:
Protein
Mol. Mass.:
110131.95
Organism:
Homo sapiens (Human)
Description:
P29320
Residue:
983
Sequence:
MDCQLSILLLLSCSVLDSFGELIPQPSNEVNLLDSKTIQGELGWISYPSHGWEEISGVDEHYTPIRTYQVCNVMDHSQNNWLRTNWVPRNSAQKIYVELKFTLRDCNSIPLVLGTCKETFNLYYMESDDDHGVKFREHQFTKIDTIAADESFTQMDLGDRILKLNTEIREVGPVNKKGFYLAFQDVGACVALVSVRVYFKKCPFTVKNLAMFPDTVPMDSQSLVEVRGSCVNNSKEEDPPRMYCSTEGEWLVPIGKCSCNAGYEERGFMCQACRPGFYKALDGNMKCAKCPPHSSTQEDGSMNCRCENNYFRADKDPPSMACTRPPSSPRNVISNINETSVILDWSWPLDTGGRKDVTFNIICKKCGWNIKQCEPCSPNVRFLPRQFGLTNTTVTVTDLLAHTNYTFEIDAVNGVSELSSPPRQFAAVSITTNQAAPSPVLTIKKDRTSRNSISLSWQEPEHPNGIILDYEVKYYEKQEQETSYTILRARGTNVTISSLKPDTIYVFQIRARTAAGYGTNSRKFEFETSPDSFSISGESSQVVMIAISAAVAIILLTVVIYVLIGRFCGYKSKHGADEKRLHFGNGHLKLPGLRTYVDPHTYEDPTQAVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKISTDDMKKVGVTVVGPQKKIISSIKALETQSKNGPVPV
  
Inhibitor
Name:
BDBM50302163
Synonyms:
3-amino-6-(4-aminopiperidin-1-yl)-4-propylthieno[2,3-b]pyridine-2-carboxamide | CHEMBL578601
Type:
Small organic molecule
Emp. Form.:
C16H23N5OS
Mol. Mass.:
333.452
SMILES:
CCCc1cc(nc2sc(C(N)=O)c(N)c12)N1CCC(N)CC1
Structure:
Search PDB for entries with ligand similarity: